Humana’s Strategy to Navigate Medicare Advantage Challenges

Humana’s recent third-quarter results, however, suggest that its recalibrated strategy to streamline Medicare Advantage (MA) offerings and invest in targeted growth may be yielding positive outcomes. As Humana pivots its approach to manage costs while bolstering its MA offerings, providers should take note of these changes, which could have broad implications for patient care and Medicare-related services. 

Strong Third-Quarter Results and a Boosted 2024 Outlook 

Humana’s third-quarter earnings surpassed initial projections, enabling the company to slightly raise its earnings guidance for 2024. Despite an early slowdown in MA enrollment, Humana now anticipates adding 265,000 new individual MA members this year, a 5% growth rate compared to the initial guidance of 225,000. This progress has been partly attributed to retaining a higher-than-expected number of MA members with increased risk scores, thereby improving reimbursement rates. 

CEO Jim Rechtin shared optimism on a recent investor call, noting the company’s “pretty significant gains” this year, attributed largely to investments in internal sales initiatives. This uptick led Humana to revise its adjusted earnings-per-share expectations for 2024, raising it from “approximately $16” to “at least $16.” Such growth highlights the potential impact of targeted investments in marketing and customer retention efforts, especially as they relate to higher-risk patient populations within the MA program. 

Challenges Looming in 2025: Balancing Investments and Earnings 

Looking ahead to 2025, Humana is cautious in its outlook, anticipating flat earnings growth despite efforts to maintain profitability in its Medicare Advantage operations. The insurer’s plans to significantly increase investments in key areas, such as improving MA star ratings and expanding its primary care business, have created a temporary drag on its financial projections. The importance of MA star ratings cannot be overstated: they directly influence the amount of revenue the Centers for Medicare & Medicaid Services (CMS) allocates to insurers, impacting Humana’s overall earnings. 

To address its star ratings, which declined steeply in recent evaluations, Humana plans to channel resources into initiatives that improve patient engagement, enhance care quality, and strengthen provider interactions. Some analysts estimate these investments could range between $500 million and $700 million, illustrating Humana’s commitment to addressing quality measures even as it carefully weighs its overall growth strategy. 

According to CEO Rechtin, balancing immediate earnings with long-term profitability is essential: “Our intent is to balance long-term earnings potential with near-term earnings progression,” he stated, indicating that Humana will not prioritize short-term gains at the expense of strategic, sustainable growth. 

Star Ratings and Reimbursement Challenges 

The Medicare Advantage star rating system plays a crucial role in the insurer’s revenue, as higher ratings typically result in increased payments from CMS. Recent changes in star ratings have posed a financial hurdle for Humana, one of the largest MA providers in the nation. With star ratings influencing billions of dollars in potential revenue, Humana’s lower ratings could lead to substantial financial losses. 

To counteract the potential revenue decrease, Humana is implementing targeted strategies aimed at improving star ratings, including increased patient engagement and comprehensive support for providers in delivering quality care. Simultaneously, Humana has filed a legal action to contest the star rating results, hoping to overturn some of the more challenging aspects of the current evaluation system. 

Growth in the CenterWell Primary Care Segment 

Despite challenges in the MA sector, Humana’s primary care business, branded as CenterWell, continues to perform well. The company has placed a strategic emphasis on expanding CenterWell, which has shown considerable growth potential and exceeded management’s expectations. Humana recently completed its acquisition of Intrepid, a Dallas-based home health and hospice provider, marking an important milestone in the expansion of CenterWell’s capabilities. 

By the end of the year, Humana expects to operate approximately 340 CenterWell locations, positioning the business as a cornerstone of its future growth strategy. The expansion aligns with Humana’s broader objective to deliver high-quality, integrated care that supports both MA and non-MA patient populations. CenterWell’s continued success may be indicative of a broader shift in healthcare, where providers are prioritizing primary and preventative care to improve outcomes and control costs for patients across various coverage types. 

Medicaid Eligibility Redeterminations and Financial Impact 

In addition to Medicare Advantage, Humana has grappled with financial strain related to the Medicaid redetermination process. As states reassess Medicaid eligibility, the remaining beneficiaries often represent higher-cost populations, leading to an increase in medical costs. Humana’s financial results reflect this trend, as disparities between the cost of care and state payment rates have grown in the wake of Medicaid eligibility redeterminations. 

Medicaid insurers across the U.S. are facing similar issues, with states adjusting their payment rates to better align with the increased cost of care. Some insurers, like Elevance, have had to lower profit guidance, while others, such as Centene and Molina, have managed to absorb the impact without adjusting projections. For Humana, Medicaid-related financial pressures have contributed to its increased medical loss ratio, which reached 90.6% in the third quarter, up from 87.6% at the same time last year. 

Investing for Future Success: A 3% Margin Target by 2027 

Amid financial hurdles, Humana has committed to achieving a 3% margin in its MA business by 2027. To meet this target, the company is strategically investing in areas such as managing medical costs, streamlining administrative functions, and focusing on profitable membership growth. These efforts are intended to stabilize Humana’s position in a challenging market while setting the stage for sustained success. 

While some stakeholders may view the near-term flat earnings projection as disappointing, the company’s commitment to quality and cost management is essential for its long-term viability in the Medicare Advantage space. Investments aimed at improving operational efficiency and fostering strong relationships with both patients and providers are critical elements of Humana’s plan to restore profitability and achieve a competitive edge in the MA program. 

Key Takeaways for Providers 

Humana’s evolving strategy in response to Medicare Advantage challenges holds several implications for healthcare providers: 

1. Focus on Patient and Provider Engagement: With Humana’s increased investments in star rating improvements, providers may find more resources and support for improving patient engagement and care quality. Humana’s focus on quality measures, such as patient satisfaction and provider interactions, may result in enhanced tools, training, or incentives for providers within its network. 

2. Impacts of Medicaid Redeterminations: The Medicaid eligibility reassessment has left providers working with a higher-cost patient population. This trend, which may continue as states adjust eligibility requirements, could create additional pressure for providers to manage care costs effectively. 

3. CenterWell’s Expansion and Primary Care Focus: As Humana expands its primary care business through CenterWell, providers affiliated with this network may have increased opportunities to offer integrated, patient-centered care. The emphasis on primary care aligns with industry trends favoring preventive care and chronic disease management, which could enhance provider roles in delivering value-based care. 

4. Long-Term Growth Investments in MA: Providers should anticipate that Humana’s ongoing investments in MA may lead to enhancements in operational processes, data management, and member support services. As Humana streamlines its MA offerings, providers could benefit from refined administrative workflows and improved access to patient data, enabling more effective care delivery. 

Humana’s adjustments provide a glimpse into the evolving dynamics of the healthcare insurance market and signal ongoing opportunities for providers to adapt and thrive in a value-focused care environment.